Cryolife inc. (CRY)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net cash flows from operating activities:
Net loss

-4,648

1,720

1,625

3,324

718

-2,840

-5,071

-5,311

-2,374

3,704

9,608

11,276

10,460

10,778

10,517

9,669

6,820

4,005

3,145

3,326

5,989

7,322

14,572

15,415

15,039

16,172

9,229

7,598

9,147

7,946

7,729

8,210

6,696

7,371

0

0

0

Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization

18,864

18,317

17,716

17,721

18,070

18,095

16,698

14,498

11,953

9,745

8,819

8,647

8,623

8,384

7,572

6,841

6,237

5,863

6,099

6,202

6,121

6,028

5,898

5,840

5,852

5,843

5,870

5,838

5,708

5,633

5,579

5,500

5,321

4,960

0

0

0

Non-cash compensation

9,513

8,799

8,221

7,327

6,927

6,325

5,952

6,240

6,371

6,919

7,363

7,255

6,711

6,328

5,979

4,784

5,365

5,089

4,427

4,966

3,728

3,436

3,619

3,326

3,303

3,240

3,268

3,224

3,191

3,162

2,901

2,842

2,770

2,790

0

0

0

Deferred income taxes

0

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-617

1,369

511

-878

-1,227

-3,444

-3,465

-2,021

-1,767

0

0

0

Gain from sale of business components

-

-

-

-

-

-

-

-

-

-

-

-

-

7,915

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash adjustments to net loss

-4,372

-2,182

-8,500

-4,703

-2,076

-2,149

1,533

-1,106

-1,062

-676

4,448

3,380

99

-268

-2,549

-2,584

-465

-268

-3,384

-2,297

-479

474

1,379

884

459

-298

-762

-1,017

-945

-683

-1,334

-1,014

-705

-767

0

0

0

Changes in operating assets and liabilities:
Receivables

-1,517

5,332

3,305

4,845

1,065

1,119

5,265

10,017

11,743

7,258

3,890

1,916

-1,032

-4,142

-1,500

1,386

777

3,809

2,848

3,618

646

4,556

782

622

1,009

1,637

1,990

-5,795

1,156

-1,363

3,021

8,381

1,059

2,230

0

0

0

Inventories and deferred preservation costs

12,395

8,125

3,177

-1,521

-826

-2,384

771

4,221

5,013

9,369

10,622

9,110

8,102

9,460

7,309

6,765

4,125

2,262

-300

-730

1,207

1,131

2,500

1,279

1,781

-193

-337

564

-291

1,598

1,220

1,962

-3,967

-2,445

0

0

0

Prepaid expenses and other assets

5,822

6,177

2,946

3,281

1,565

2,407

2,409

1,890

2,130

2,968

2,479

2,394

1,961

-515

-34

230

36

1,187

882

1,546

2,069

2,771

3,117

2,198

1,509

706

536

443

284

583

441

845

955

617

0

0

0

Accounts payable, accrued expenses, and other liabilities

1,549

251

2,490

-4,456

-2,241

-8,870

-2,891

1,646

-62

8,727

3,561

3,580

3,354

4,720

-1,860

-518

1,389

-656

1,750

689

-1,269

-64

650

1,645

3,857

572

1,170

-5,433

-3,706

529

-2,441

4,542

-346

-772

0

0

0

Net cash flows provided by operating activities

17,301

15,827

25,288

20,748

20,769

9,881

5,337

-179

-2,793

10,803

9,871

15,903

22,178

19,719

16,089

12,086

11,554

11,442

14,812

12,483

11,454

8,118

8,798

13,566

15,903

16,772

19,289

18,097

16,016

18,990

14,052

13,787

14,690

16,751

0

0

0

Net cash flows from investing activities:
Decrease in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures

9,417

8,072

6,733

5,777

4,864

5,786

5,523

5,650

6,714

6,632

8,071

8,925

7,412

6,198

3,815

2,906

3,255

3,490

4,271

4,230

4,328

4,310

4,322

4,353

4,387

4,338

4,101

3,779

3,358

3,070

2,755

2,900

2,964

2,538

0

0

0

Acquisition of JOTEC, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

91,152

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of business components

-

-

-

-

-

-

-

-

-

-

-

-

740

19,795

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

1,002

871

738

953

1,159

929

741

1,140

58

86

181

-620

179

126

114

93

93

610

-70

-31

857

1,004

1,413

1,397

548

-10

-610

-617

-14

-9

801

1,162

615

547

0

0

0

Net cash flows used in investing activities

-25,419

-23,943

-22,471

-6,730

-6,023

-6,715

-171,334

-171,120

-171,842

-171,048

-12,512

-13,305

-13,077

-78,907

-72,789

-71,859

-70,091

-4,486

-3,349

-3,347

-5,224

-5,353

9,470

9,455

10,270

10,877

-5,310

-5,966

-23,203

-22,920

-21,596

-24,686

-28,210

-27,716

0

0

0

Net cash flows from financing activities:
Proceeds from revolving line of credit

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of term loan

2,775

2,780

2,764

2,783

2,779

2,790

3,176

3,416

5,232

4,994

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

2,289

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

75,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and issuance of common stock

3,793

4,758

4,580

6,493

5,277

3,854

4,320

2,304

2,445

3,126

2,686

2,941

2,754

2,203

2,234

1,846

1,579

1,526

2,674

2,878

3,001

2,675

2,764

2,469

2,335

2,207

880

426

417

330

293

425

686

694

0

0

0

Cash dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,408

3,396

3,385

3,373

3,295

3,217

3,134

3,052

2,967

0

0

0

-

-

-

-

-

-

-

-

Repurchases of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,523

1,370

1,299

2,870

3,310

4,920

4,881

3,145

3,064

0

0

0

Redemption and repurchase of stock to cover tax withholdings

2,079

2,743

2,738

2,953

2,964

2,100

2,099

1,873

1,826

1,614

1,698

1,687

1,434

697

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-702

-728

-574

-559

-733

-902

-1,795

-1,600

-1,250

-910

43

269

388

617

1,838

1,688

1,135

458

606

526

994

738

-357

-353

-318

-87

-476

-475

-551

-143

-441

-492

-479

-476

0

0

0

Net cash flows provided by (used in) financing activities

28,237

-1,493

-2,120

-426

-1,823

-2,562

144,887

143,052

141,774

143,245

-2,885

-2,392

-167

73,428

72,537

72,120

70,918

-2,810

-2,603

-5,045

-6,449

-6,953

-6,075

-3,851

-2,036

-3,051

-4,074

-4,383

-5,283

-4,715

-5,754

-4,948

-2,938

-2,846

0

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted securities

2,683

1,667

1,169

944

760

879

1,408

760

658

412

578

235

4

-317

-203

-487

33

67

-186

114

-131

-80

-49

-32

-6

36

-16

-15

-44

-51

38

45

22

19

0

0

0

Increase (decrease) in cash, cash equivalents, and restricted securities

22,802

-7,942

1,866

14,536

13,683

1,483

-19,702

-27,487

-32,203

-16,588

-4,948

441

8,938

13,923

15,634

11,860

12,414

4,213

8,674

4,205

-350

-4,268

12,144

19,138

24,131

24,634

9,897

7,742

-12,522

-8,696

-13,298

-15,847

-16,458

-13,811

0

0

0